AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2013
Jan 30, 2013
31523_dirs_2013-01-30_20276082-0eb6-40ce-beca-36a02c6647d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-06-04
Reporting Person: Quimi Daphne (Corporate Controller)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-28 | Stock Options (right to buy) | $3.53 | A | 8750 | Acquired | 2023-01-28 | Common Stock (8750) | Direct |
| 2012-06-04 | Stock Options (right to buy) | $4.38 | A | 8750 | Acquired | 2022-06-04 | Common Stock (8750) | Direct |
Footnotes
F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 28, 2014. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2014, with the final installment vesting on January 1, 2017.
F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 4, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2013, with the final installment vesting on June 1, 2016.